Abl Protein Tyrosine Kinase (Abl)

  • This product was discontinued on January 01, 2013
icon_recomb icon_NEBU 30 degrees icon_HI_65

Ordering Information

  • Discontinued
  • Product Information
    Abl Protein Tyrosine Kinase (AbI) is a truncated form of the v-AbI Protein Tyrosine Kinase, a partner in the Gag-Abl fusion protein of the Abelson murine leukemia virus. Abl contains 407 amino acids (residues 237-643 of the p120-gag-abl polyprotein), which include the kinase catalytic domain, SH2 domain on the N-terminus and the I237M mutation. This truncated form of v-Abl is identical to the normal c-Abl (1-3). Abl is autophosphorylated on tyrosine(s)(2). 


    • Protein tyrosine kinase
    • Abelson Murine Leukemia Virus, recombinant (E. coli)

    Product Source

    Isolated from a strain of E. coli that carries the truncated AbI Protein Kinase encoded by the Abelson murine leukemia virus under the control of a T7 expression system (kindly provided by Dr. S. Goff).

    Recognition Determinant

    The recognition motif for phosphorylation by Abl is I/V/LYXXP/F. Abl, like many cytosolic protein tyrosine kinases, preferentially phosphorylates sites recognized by its own SH2 domain, selects substrates with large hydrophobic amino acids at the +3 position and β-branched amino acids at the -1 position (4).

    Reagents Supplied

    The following reagents are supplied with this product:

    Store at (°C) Concentration
    NEBuffer™ for Protein Kinases (PK) -20 10 X
    Product Categories:
    Discontinued Products
    • Properties and Usage
    • Related Products
    • Notes
    • References
  • Protocols & Manuals
  • Other Tools & Resources
  • Quality & Safety
    • Quality Control Assays
    • Safety Data Sheets
    • Datacards
  • Legal Information
    • Legal And Disclaimers
Loading Spinner